Cargando…
Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEEN y SED. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683264/ https://www.ncbi.nlm.nih.gov/pubmed/34957378 http://dx.doi.org/10.1016/j.endinu.2021.11.003 |
| _version_ | 1784617376898088960 |
|---|---|
| author | González López, Javier Escorcio Faria, Dianis Riestra Fernández, María |
| author_facet | González López, Javier Escorcio Faria, Dianis Riestra Fernández, María |
| author_sort | González López, Javier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8683264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | SEEN y SED. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86832642021-12-20 Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) González López, Javier Escorcio Faria, Dianis Riestra Fernández, María Endocrinol Diabetes Nutr Carta Científica SEEN y SED. Published by Elsevier España, S.L.U. 2022-11 2021-12-18 /pmc/articles/PMC8683264/ /pubmed/34957378 http://dx.doi.org/10.1016/j.endinu.2021.11.003 Text en © 2021 SEEN y SED. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta Científica González López, Javier Escorcio Faria, Dianis Riestra Fernández, María Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title | Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title_full | Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title_fullStr | Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title_full_unstemmed | Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title_short | Insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la COVID-19 (BNT162b2 Pfizer-BioNTech) |
| title_sort | insuficiencia suprarrenal aguda en paciente con panhipopituitarismo posterior a la vacunación contra la covid-19 (bnt162b2 pfizer-biontech) |
| topic | Carta Científica |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683264/ https://www.ncbi.nlm.nih.gov/pubmed/34957378 http://dx.doi.org/10.1016/j.endinu.2021.11.003 |
| work_keys_str_mv | AT gonzalezlopezjavier insuficienciasuprarrenalagudaenpacienteconpanhipopituitarismoposterioralavacunacioncontralacovid19bnt162b2pfizerbiontech AT escorciofariadianis insuficienciasuprarrenalagudaenpacienteconpanhipopituitarismoposterioralavacunacioncontralacovid19bnt162b2pfizerbiontech AT riestrafernandezmaria insuficienciasuprarrenalagudaenpacienteconpanhipopituitarismoposterioralavacunacioncontralacovid19bnt162b2pfizerbiontech |